Tasheema Prince

Long-term survival in prostate cancer patients can be predicted by prostate-specific antigen (PSA) values at 2 years posttreatment, say researchers from Memorial Sloan-Kettering Cancer Center.

Low levels of vitamin D has been linked to poor prognosis in patients with aggressive lymphoma, according to a new study presented at the American Society of Hematology Annual Meeting and Exposition in New Orleans in December.

High intake of sweetened beverages may be associated with an increased risk for breast cancer recurrence among women previously treated for early-stage disease, say researchers who presented their finings at the Frontiers in Cancer Prevention Research Conference in Houston in December.

Scientists have improved a method for bone marrow transplantation from mismatched donors that would help restore the immune system quicker, according to findings presented at the American Society of Hematology Annual Meeting and Exposition in New Orleans in December.

Multiple myeloma patients experience high response rates when treated with a drug regimen consisting of 3 drugs, according to data presented at the American Society of Hematology Annual Meeting and Exposition in New Orleans in December.

Women at risk for breast cancer are unwilling to accept the potential harms of tamoxifen in order to reduce their chances of breast cancer, say researchers who published their study in Breast Cancer Research and Treatment (2009 Nov 12 [Epub ahead of print]).

Smokers can use a virtual anti-smoking program to help reduce tobacco addiction, according to research published in CyberPsychology and Behavior (2009; 12[5]:477-483).

Women with early-stage HER2-positve breast cancer are at significant risk of recurrence, according to a study published in the Journal of Clinical Oncology (2009 Nov 2 [Epub ahead of print].

Patients who are at high-risk for developing lung cancer can be identified through the use of a questionnaire, according to a study featured in the Journal of Thoracic Oncology (November 2009;4[11]:1347-1351).

Two FDA-approved drugs may be as effective in treating cervical cancer in human cells as they are in mice, say researchers at the University of Wisconsin-Madison School of Medicine and Public Health.